1988Congenital AnomaliesOpen access

Effects of Folic Acid and Folinic Acid on Pyrimethamine Teratogenesis in Rats

Gen Kudo, Eiichi KOKUE, Toyoaki HAYAMA

Open full text 4 citations

Abstract

ABSTRACT The effects of folic acid (FA) and folinic acid (FNA) on the tera‐togenicity of the antifolate drug pyrimethamine (PYR) were examined in rats. PYR and FA were orally administered with mashed feed. FNA was intraperitoneal‐ly injected. The drugs were administered for 5 days of day 11–15 of gestation. Six groups were made; G‐I PYR 1.6 (mg/kg/day), G‐II PYR 3.6, G‐HI PYR 1.6 + FA 50, G‐IV PYR 3.6 + FNA 12, G‐V FA 50, G‐VI control. No malformations were found in G‐I, IV, V and VI. All fetuses in G‐II and HI had malformations. Main malformations in G‐II and III were cleft palate and brachygnathia. Accordingly it might be demonstrated that the teratogenicity of PYR was potentiated by concurrent FA in rats.

Open-access reader

About this research paper

What this paper is about

ABSTRACT The effects of folic acid (FA) and folinic acid (FNA) on the tera‐togenicity of the antifolate drug pyrimethamine (PYR) were examined in rats. PYR and FA were orally administered with mashed feed. FNA was intraperitoneal‐ly injected. The drugs were administered for 5 days of day 11–15 of gestation. Six groups were made; G‐I PYR 1.6 (mg/kg/day), G‐II PYR 3.6, G‐HI PYR 1.6 + FA 50, G‐IV PYR 3.6 + FNA 12, G‐V FA 50, G‐VI control. No malformations were found in G‐I, IV, V and VI. All fetuses in G‐II and HI had malformations. Main malformations in G‐II and III were cleft palate and brachygnathia. Accordingly it might be demonstrated that the teratogenicity of PYR was potentiated by concurrent FA in rats.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ABSTRACT The effects of folic acid (FA) and folinic acid (FNA) on the tera‐togenicity of the antifolate drug pyrimethamine (PYR) were examined in rats. PYR and FA were orally administered with mashed feed. FNA was intraperitoneal‐ly injected. The drugs were administered for 5 days of day 11–15 of gestation. Six groups were made; G‐I PYR 1.6 (mg/kg/day), G‐II PYR 3.6, G‐HI PYR 1.6 + FA 50, G‐IV PYR 3.6 + FNA 12, G‐V FA 50, G‐VI control. No malformations were found in G‐I, IV, V and VI. All fetuses in G‐II and HI had malformations. Main malformations in G‐II and III were cleft palate and brachygnathia. Accordingly it might be demonstrated that the teratogenicity of PYR was potentiated by concurrent FA in rats.

Key concepts: Folinic acid, Pyrimethamine, Folic acid, Teratology, Pharmacology, Antifolate, Chemistry, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Folic Acid and Folinic Acid on Pyrimethamine Teratogenesis in Rats — Research Paper | ScholarLens